Recent Articles

• 
  MedTech

  Korean Spinal Treatment Technology Wins U.S. Patent

  Amid a trend of increasing segmentation and sophistication in domestic spinal treatment technology, medical staff who have accumulated both clinical and research outcomes are drawing attention. Park Kyung-woo (photo), CEO and Director leading the Spine Center at Seoul Kwang Hye Hospital, has over th

  2026.05.13
• 
  MedTech

  KRW 120 billion Plan Backs Futuristic Tertiary Hospital

  Bird’s-eye view of Korea University Anam Hospital. Korea University Anam Hospital has announced its “Advanced Critical Care Project.” The hospital plans to strengthen its role as a final treatment institution focusing on severe, emergency, trauma, and cardio-cerebrovascular diseases. Provided by Kor

  2026.05.13
• 
  Global Business

  Celltrion to Acquire French Healthcare Firm Giphar

  Celltrion’s headquarters signboard. Provided by Celltrion Celltrion announced on the 12th that it has acquired “Gifrer,” a French healthcare company with a 114-year history. The company is assessed to have expanded its business scope into the European generic and over-the-counter (OTC) medicine mark

  2026.05.12
• 
  Diagnostics / Monitoring

  In the Pet 20-Year Era, Why Sentinel Lymph Node Evaluation Matters

  When discussing cancer treatment in companion animals, owners often ask, “Isn’t it over once the tumor is properly removed?” Surgically removing the visible mass is indeed an important starting point of treatment. However, oncology poses a more critical question: “Has this cancer already begun to sp

  2026.05.11
• 
  Medical / Research

  KMI Grant Becomes Springboard for Young Researchers

  Executives and employees of KMI Korea Medical Institute and external principal investigators pose for a commemorative photo at the “2026 KMI Public Research Grant Program Agreement Ceremony” held on April 29. “This KMI Leap-type project is the first research grant of my career, so it has special mea

  2026.05.11
• 
  Biopharma

  U.S. Advances Pill Diet Drugs, Koreans Left Waiting

  Getty Images Bank 《Interest in ‘oral obesity drugs’ landing in KoreaIn the United States, the era of ‘oral obesity drugs’ has opened following injectable treatments, transforming not only how people lose weight but also the broader consumption landscape. A flood of small-portion high‑protein foods t

  2026.05.09
• 
  Biotech

  Daewoong Pharma Starts Monthly Obesity Drug Trials with Tionlab

  Daewoong Pharmaceutical and TionLab Therapeutics are pushing forward joint development of a once-monthly long-acting obesity treatment. Provided by Daewoong Pharmaceutical Daewoong Pharmaceutical is pursuing development of a “dream obesity drug” that can treat obesity with a once-monthly injection b

  2026.05.08
• 
  Medical / Drug Development

  Hanmi Restructures to Focus on Obesity, Cancer Drugs

  Headquarters of Hanmi Pharmaceutical. Provided by Hanmi Pharmaceutical Hanmi Pharmaceutical announced on the 8th that it had carried out an organizational restructuring, aimed at strengthening competitiveness in its obesity treatment and new drug businesses. This is the first full-scale organization

  2026.05.08
• 
  Global Business

  GC Pharma Q1 Operating Profit KRW 11.7 Billion, Up 46.3% on AliGlo

  Panoramic view of GC Green Cross headquarters. Courtesy of GC Green Cross GC Green Cross achieved improved earnings in the first quarter of this year, driven by the growth of its new immune globulin drug “ALYGLO.” The company is assessed to be entering a full-fledged phase of profitability recovery,

  2026.05.08
• 
  Medical / Drug Development

  LG Chem Launches Infertility Drug Utipro, Expands Options

  Utipro. Provided by LG Chem. LG Chem announced on the 8th that it has launched “Utipro Injection 25 mg (Utipro),” an infertility treatment for luteal phase support. As the domestic infertility treatment market grows rapidly, the company is seen as strengthening its women’s health business by expandi

  2026.05.08